Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results

Eye

Volumn 23, Issue 6, 2009, Pages 1275-1281

  Mones J M ^a   Amselem, L ^a   Serrano, A ^a   Garcia, M ^a   Hijano, M ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Anti VEGF therapy; Choroidal neovascularization; Myopic CNV; Neovascular membrane; Pathologic myopia; Ranibizumab

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INJECTION; MALE; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDIES; VISUAL ACUITY; VISUAL PERCEPTION; YOUNG ADULT;

EID: 67650683976     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.88     Document Type: Article

References (8)

1. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983; 67: 209-213.
2. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984; 91: 1573-1581.
3. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001; 108: 841-852.
4. Nguyen QD, Shah S, Tatlipinar S, Do DV, Anden EV, Campochiaro PA. Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. Br J Ophthalmol 2005; 89: 1368-1370.
5. Yamamoto I, Rogers HA, Reichel E, Yates P, Ducker J Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularization secondary to pathologic myopia. Br J Ophthalmol 2007; 91: 157-160.
6. Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007; 91: 161-165.
7. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006; 141: 456-462.
8. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptative response to ischemic injury. Am J Pathol 2007; 171(1): 53-67.